Research reports that 90% of cancers are caused by unhealthy lifestyle habits

Share This Post

Medical experts say that 90% of cancer patients are caused by unhealthy life habits, not DNA plays a leading role. Diet, sunlight, smoking, and disease have a “burn-up” effect on cancer, not caused by bad DNA. Dr. Smith of the British Cancer Institute said that healthy lifestyles such as non-smoking, maintaining a healthy weight, eating healthy food and quitting alcohol cannot ensure that people do not suffer from cancer, but can significantly reduce the probability of cancer.

This suggestion is not surprising. Scientists have divided how many cancer cases are due to people’s living habits, and how many cancer cases are inevitable. The controversy began 1 year ago, when studies reported that most cancer cases occurred due to DNA errors and occurred at random body ages and cell divisions. This means that most cancer patients are due to “bad luck” rather than unhealthy living habits.

At present, the latest research has reached the opposite conclusion. Dr. Yusuf Hannun of Stony Brook University pointed out that although “luck” has a certain effect, people’s unhealthy living habits can seriously affect the incidence of cancer. . These unhealthy lifestyle habits include: diet, drinking, smoking, sunlight, certain viral infections, pollution, and other factors that have not yet been determined.

The research report was published in the journal Nature, and the bad genes inherited from parents are only a cause of a few cancer cases. The results of this study confirm that most cancer cases are caused by environmental factors. If these potential factors can be identified, the incidence of cancer can be controlled.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy